3D Medicines, Inc. (HK:1244) has released an update.
3D Medicines Inc. has officially adopted a Chinese name for dual foreign name representation and announced that a new Chinese stock short name will be effective for trading on the Stock Exchange from August 5, 2024. This change is not expected to affect shareholder rights or the company’s operations and finances, and current share certificates will remain valid.
For further insights into HK:1244 stock, check out TipRanks’ Stock Analysis page.
